推荐应用
The epidermal growth factor receptor (EGFR) subfamily of receptor tyrosine kinases comprises four members: EGFR (also known as HER1, ErbB1 or ErbB), ErbB2 (Neu, HER2), ErbB3 (HER3), and ErbB4 (HER4). The amino acid 25-378 of EGFR encodes the most common extracellular domain truncation mutant, termed EGFRvIII. It has been proved that EGFRvIII is relevant in a number of cancer types. EGFRvIII is tumor specific, and has not been found in normal tissues. EGFRvIII is highly tumorigenic, and can cause aggressive tumor phenotype, with increased invasion, proliferation, angiogenesis, and evasion of apoptosis. This EGFRvIII-mediated enhanced tumourigenicity combined with the lack of EGFRvIII expression in normal tissue makes it an ideal therapeutic targets.
高纯度、高活性、低内毒素、高批间一致性
Tris-Bis PAGE

SEC-HPLC

ELISA Data

FACS Data

-25 ~ -15℃保存,收到货之后有效期1年。 复溶后, 无菌条件下,-85 ~ -65℃保存,3个月有效期。
【应用方向】HER2与HER3:ErbB受体家族协同靶向治疗的核心工具蛋白
153
2026-08-31
【应用方向】HER2:抗体药物研发的核心工具蛋白
155
2026-08-31
【应用方向】抗体药研发中常见靶点蛋白及其应用
194
2026-08-31
【应用方向】靶点蛋白在抗体药研发中的应用
148
2026-08-31
【应用方向】GPC3:HCC靶向治疗的核心靶点与药物研发探索
1955
2026-04-24
【应用方向】TROP2:从分子机制到实体瘤靶向治疗的研究进展
1908
2026-04-24
【应用方向】4-1BB-4-1BBL共刺激轴的T细胞活化机制
1160
2026-04-22
【应用方向】TNFR蛋白家族概述
1108
2026-04-21
【应用方向】Klotho蛋白:编织生命之线的抗衰老分子
1285
2026-04-20
【应用方向】药靶明星 | FGFRs家族蛋白解析
956
2026-04-20
【应用方向】解析Fc受体:抗体药物研发的核心靶点与评价基石
969
2026-04-20
【应用方向】FcγR家族:抗体药物研发的基石与核心靶点
1047
2026-04-20
【应用方向】CD47-SIRPα轴研究工具与药物开发应用
878
2026-04-20
【技术讲解】细胞因子科学选型--常见问题解答
11245
2026-09-21
【技术讲解】ADC药物研究相关靶点汇总
19456
2025-07-30





